New pacing approach aims to boost heart failure therapy success
NCT ID NCT02962791
First seen Feb 06, 2026 · Last updated May 20, 2026 · Updated 13 times
Summary
This study tested whether using three pacing sites instead of the usual two could help more people with heart failure benefit from cardiac resynchronization therapy (CRT). About 25-30% of patients do not respond to standard CRT. The trial planned to enroll adults with severe heart failure who needed a new CRT device, but it was stopped early after only 36 participants. The main goal was to see if triple-site pacing improved heart structure and function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC RESYNCHRONIZATION THERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rouen University Hospital
Rouen, France
Conditions
Explore the condition pages connected to this study.